AHA 2024: CardioNerds
AHA 2024: CardioNerds
Advertisement
Rob DillardAHA 2024: CardioNerds | November 27, 2024
The U.S. FDA recently approved Attruby (acoramidis) for adults with ATTR-CM to reduce cardiovascular death, hospitalization.
Read More
Amit Goyal, MDAHA 2024: CardioNerds | November 26, 2024
A study highlights the significant HCRU and costs associated with ATTR-CM.
Amit Goyal, MDAHA 2024: CardioNerds | November 26, 2024
Promising long-term outcomes from the ongoing OLE of the ATTRibute-CM trial highlight the efficacy of acoramidis.
Rob DillardAHA 2024: CardioNerds | November 26, 2024
A case study highlights the importance of avoiding anchoring bias in the diagnosis of cardiac amyloidosis.
Rob DillardAHA 2024: CardioNerds | November 26, 2024
The diagnosis of AL amyloidosis requires a high index of suspicion to render a prompt diagnosis and appropriate treatment.
Rob DillardAHA 2024: CardioNerds | November 20, 2024
A study further supports the efficacy of acoramidis in the treatment of people with ATTR-CM.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
People with amyloidosis have a significantly higher prevalence of atrial fibrillation.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
An AI model for detecting ATTR-CA yields solid diagnostic results.
Rob DillardAHA 2024: CardioNerds | November 18, 2024
On average, the readability of patient educational materials on cardiac amyloidosis fails to meet NIH standards.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
A deep-learning model is able to detect ATTR-CM with robust efficacy.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
Practical strategies are needed in health centers to ensure patients with ATTRv receive optimal care.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
Artificial intelligence-enhanced ECG models can effectively detect cardiac amyloidosis.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
Individuals with transthyretin amyloid cardiomyopathy who have clonal hematopoiesis have an increased risk of mortality.
Advertisement
Advertisement
Advertisement
Latest News

December 9, 2024